Single Centre Experience and Outcome of Primary Percutaneous Coronary Intervention for Patients with ST-Segment-Elevation Myocardial Infarction
نویسندگان
چکیده
Background: Primary percutaneous coronary intervention is an emergent coronary angiography and mechanical reperfusion of the infarct-related artery performed in patients with ST-segment elevation myocardial infarction. The present study aimed to determine the outcomes of primary percutaneous coronary intervention in a tertiary care cardiac centre. Aims: The present study carried out with the aim to determine the outcomes of primary percutaneous coronary intervention in a tertiary care cardiac centre. Methods: We evaluated 548 patients presented treated for ST-segment elevation myocardial infarction with primary percutaneous coronary intervention at Sri Venkateswara Institute of Medical Sciences, Tirupati, India from January 2011 to December 2012. Results: Total 548 patients were included in this study. Mean age of patients was 54.5 ± 11.5 years. Cardiogenic shock, complete heart block and ventricular tachycardia / ventricular fibrillation was encountered in 31 (5.7%), 40 (7.3%) and 49 (8.9%) patients respectively at hospital admission. The average door to balloon time was 62.5 ± 15.0 minutes. Thrombus aspiration was performed in 159 (29.0%) patients during the index procedure. During hospital stay, in-hospital mortality was 20 (3.6%) out of which 15 (2.7%) patients died from cardiac cause. Target vessel revascularization, major bleeding and minor bleeding observed in 5 (0.9%), 5 (0.9%) and 11 (2.0%) cases respectively. Result of this six-month outcome of the studied showed 5 (0.9%) deaths and 5 (0.9%) incidence of target vessel revascularization. Conclusions: Our data suggest that primary percutaneous coronary intervention for ST-segment elevation myocardial infarction can be safely performed in a regional institution with acceptable door to balloon time and low major adverse cardiac event rates.
منابع مشابه
Comparison of in-Hospital Outcome after Percutaneous Coronary Intervention Between Patients with Anterior Myocardial Infarction and Those With or Without Ramus Intermedius
Introduction: Primary percutaneous coronary intervention (PPCI) is used for the treatment of ST segment elevation myocardial infarction (STEMI). Anterior STEMI is associated with adverse outcomes, and it is possible that the presence of ramus intermedius (RI) would inversely affect the outcome. This research involved the evaluation of the influence of RI presence on clinical ou...
متن کاملNo-Reflow Phenomenon in Patients with ST-Elevation Acute Myocardial Infarction, Treated with Primary Percutaneous Coronary Intervention: A Study of Predictive Factors
Introduction: No-reflow phenomenon in coronary vessels, manifested in some patients with reperfused acute myocardial infarction (MI), is associated with poor clinical and functional outcomes. Therefore, evaluation of predisposing risk factors can be helpful in risk assessment and identification of patients at higher risk. Herein, we aimed to study the predictive factors for the development of...
متن کاملComparison of the Success Rate of Treatment with Primary Percutaneous Coronary Intervention PCI versus Thrombolytic Treatment in Patients with ST-Elevation Myocardial Infarction in Local Hospitals in Iran
Background and Objective: Acute myocardial infarction (MI) is caused due to coronary artery occlusion and divided into two forms of ST-elevation (STEMI) and non-ST-elevation (NSTEMI) myocardial infarction. This study aimed to determine the success rate of treatment with primary PCI (percutaneous coronary intervention) versus thrombolysis in the establishment of perfusion and to evaluate the sho...
متن کاملPlatelet-To-Lymphocyte Ratio as a Predictor of No-Reflow after Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis
Introduction: No-reflow increases the complications and mortality rate of primary percutaneous coronary intervention (PCI). Therefore, it is important to identify patients at a higher risk of developing no-reflow. This study aimed to systematically review the prognostic value of the platelet-to-lymphocyte ratio (PLR) to predict no-reflow. Materials and Methods:</s...
متن کاملIntracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration
BACKGROUND Administration of abciximab during primary percutaneous coronary intervention is an effective adjunctive therapy in the treatment of patients with ST-segment elevation myocardial infarction. Recent small-scaled studies have suggested that intracoronary administration of abciximab during primary percutaneous coronary intervention is superior to conventional intravenous administration....
متن کامل